Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam for slow endotracheal intubation under spontaneous breathing in obstructive sleep apnea syndrome
ChiCTR2000033871Phase 4Not yet recruiting
- Sponsor
- Foshan Fosun Chancheng Hospital
- Start
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of remimazolam in obstructive sleep apnea hypopnea syndrome (OSAHS) (3 arms), sponsored by Foshan Fosun Chancheng Hospital. Primary endpoint: Success rate of sedation. Planned start Jun 2020; status: not yet recruiting.
02
Drugs
remimazolam
03
Conditions
obstructive sleep apnea hypopnea syndrome (OSAHS)
Beyond the preview
Go deeper on ChiCTR2000033871.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000033871.